Conatumumab Shows Promise in Treating Peripheral Artery Disease by Promoting Angiogenesis
A preclinical study indicates that Conatumumab, a cancer drug, can effectively treat peripheral artery disease (PAD) by promoting the growth of new blood vessels.
Cancer Drug Conatumumab Shows Promise in Treating Peripheral Artery Disease
Preclinical studies demonstrate that Conatumumab, previously tested as a cancer drug, effectively treats Peripheral Artery Disease (PAD).
© Copyright 2025. All Rights Reserved by MedPath